ライフサイエンスコーパス: RyR1

1 hannels (CaV1.1) and the ryanodine receptor (RyR1).

2 (CaV1.1) and the type 1 ryanodine receptor (RyR1).

3 r calcium channel type 1 ryanodine receptor (RyR1).

4 ceptor and calcium (Ca(2+)) release channel (RyR1).

5 ease channel, the ryanodine receptor type 1 (RyR1).

6 een the DHPR and the Ca(2+) release channel (RyR1).

7 mutations within ryanodine receptor type 1 (RYR1).

8 the single-channel function of skeletal RyR (RyR1).

9 a Ca(2+) sensor that regulates the gating of RyR1.

10 ependent on different structural elements of RyR1.

11 n conformational coupling between CaV1.1 and RyR1.

12 to that in myotubes, despite the absence of RyR1.

13 that FKBP12.6 activates and FKBP12 inhibits RyR1.

14 etween the C-terminal tail of the beta1a and RyR1.

15 l as stimulus-coupled Ca(2+) release through RyR1.

16 r conditions that altered the redox state of RyR1.

17 ural models of the open and closed states of RyR1.

18 ) or central (residues 2157-2777) regions of RyR1.

19 namer that binds the Ca(2+)-release channel, RyR1.

20 aM that may play a role in the regulation of RyR1.

21 scle fibres there is a functional reserve of RyR1.

22 the sarcoplasmic reticulum (SR) through the RyR1.

23 establish physical links between CaV1.1 and RyR1.

24 RyR1/2 transcript levels increased, whereas those of RyR

25 -EM) snapshots of ryanodine receptor type 1 (RyR1), a calcium-activated calcium channel engaged in th

26 inding protein 12 subunit (FKBP12) increases RyR1 activity and impairs muscle function.

27 nishing S-palmitoylation directly suppresses RyR1 activity as well as stimulus-coupled Ca(2+) release

28 gh additive to) any indirect consequences to RyR1 activity that arise as a result of K(+) fluxes acro

29 in multiple functional domains implicated in RyR1 activity-regulating interactions with the L-type Ca

30 egligible effects on Ca(2+) release flux and RyR1 activity.

31 ion is strongly regulated by temperature and RyR1 activity.

32 ation converts MCa from positive to negative RyR1 allosteric modulator.

33 vides the first evidence to our knowledge of RyR1 alterations as a proximal mechanism underlying VIDD

34 Missense mutations resulting in 2 homozygous RYR1 amino acid substitutions (E989G and R3772W) and 2 c

35 ur open-channel model is consistent with the RyR1 and cardiac RyR (RyR2) open-channel structures repo

36 TBBPA activated RyR1 and inhibited DHPR and SERCA, inducing a net efflux

37 C-4/HDAC-5 exhibited decreased expression of RYR1 and of muscle-specific miRNAs, whereas acute knock-

38 l muscle weakness, increased Nox4 binding to RyR1 and oxidation of RyR1 were present in a mouse model

39 different effects of FKBP12 and FKBP12.6 on RyR1 and RyR2 channel gating provide scope for diversity

40 In recent years, structures for both RyR1 and RyR2 have been solved at near-atomic resolution

41 ncurrently bind to and functionally modulate RyR1 and RyR2, but this does not involve direct competit

42 This review addresses the modulation of RyR1 and RyR2, in addition to the impact of such discove

43 y stabilizing the ryanodine receptors (RyRs; RyR1 and RyR2, respectively).

44 With respect to the functional regulation of RyR1 and RyR2, the FKBP12E31Q/D32N/W59F mutant lost all

45 .e. CaM binding), with Ki > 10 mum, for both RyR1 and RyR2.

46 aM is essential for dantrolene inhibition of RyR1 and RyR2.

47 in several genes including MTM1, DNM2, BIN1, RYR1 and TTN.

48 Ryanodine receptor types 1 (RyR1) and 2 (RyR2) are calcium release channels that are

49 d labeling of the type 1 ryanodine receptor (RyR1) and fluorescence resonance energy transfer (FRET)

50 tact, functional ryanodine receptors type I (RyR1) and II (RyR2) from skeletal and cardiac muscle, re

51 Inhibitors of ryanodine receptors (RyR1) and L-type Ca(2+) channels protect voltage-induced

52 ells by expression of CaV1.1, beta1a, Stac3, RyR1, and junctophilin2.

53 Mutations in skeletal muscle RyR (RyR1) are associated with congenital diseases such as ma

54 Mutations in ryanodine receptor 1 (RyR1) are often associated with myopathies with microsco

55 from skeletal muscle sarcoplasmic reticulum (RyR1) are shown to be potent inhibitors of single-channe

56 Ca(2+) release channel, ryanodine receptor (RyR1), are essential for excitation-contraction coupling

57 nt); both results suggest a reduction of the RyR1 arrays.

58 of function, muscle atrophy) and identifies RyR1 as a potential target for therapeutic intervention.

59 RYR1-associated myopathies should be included in the dif

60 FRET and inhibit [(3)H]ryanodine binding to RyR1 at nanomolar Ca(2+).

61 oteins compete for the same binding sites on RyR1 because channels that are preactivated by FKBP12.6

62 SR vesicles enriched in RyR1 bound approximately 48 [(3)H]S107 per RyR1 tetramer

63 We have also re-determined the location of RyR1-bound Ca(2+)-CaM using uniform experimental conditi

64 a mechanism dependent on the conformation of RyR1-bound CaM.

65 Apocalmodulin (apo-CaM) weakly activates RyR1 but inhibits RyR2, whereas Ca(2+)-calmodulin inhibi

66 FKBP12E31Q/D32N/W59F activated RyR1 but was not capable of activating RyR2.

67 g the activity of type 1 ryanodine receptor (RyR1), but its potential to influence physiological exci

68 indings demonstrate functional regulation of RyR1 by a previously unreported post-translational modif

69 odel suggested that luminal Ca(2+) activates RyR1 by accessing a recently identified cytosolic Ca(2+)

70 Thus, physiological redox regulation of RyR1 by endogenously generated hydrogen peroxide is exer

71 Both compounds also decrease RyR1 Ca(2+) leak in human skinned skeletal muscle fibers

72 rtebrates, this depends on activation of the RyR1 Ca(2+) pore in the SR, under control of conformatio

73 onsistent with mislocalization of Serca1 and Ryr1, calcium handling was drastically altered in Rbfox1

74 7, a small molecule drug that stabilizes the RyR1-calstabin1 interaction, prevented VIDD.

75 he ryanodine receptor/Ca(2+)-release channel RyR1 can be enhanced by S-oxidation or S-nitrosylation o

76 the skeletal muscle ryanodine receptor gene (RYR1) can cause susceptibility to malignant hyperthermia

77 ease channel, the type 1 ryanodine receptor (RYR1), cause malignant hyperthermia susceptibility (MHS)

78 cle fibers subjected to voltage-clamp and on RyR1 channel activity after incorporating sarcoplasmic r

79 1, its dioxole derivative, and 4-MmC inhibit RyR1 channel activity by virtue of their electron donor

80 beta1a490-508 also increased RyR1 channel activity in bilayers and Cav1.1 currents in

81 RyR1 channel activity is modulated by the beta1a subunit

82 feine stimulation, suggesting a reduction in RyR1 channel activity.

83 ndicate that both glycines are important for RyR1 channel function by providing flexibility and minim

84 To better understand RyR1 channel function, we investigated the molecular mec

85 ines, Gly-4934 and Gly-4941, that facilitate RyR1 channel gating by providing S6 flexibility and mini

86 We find that RyR1 channels from Tric-a KO mice respond normally to cy

87 Mutant RyR1 channels incorporated into lipid bilayers were less

88 The oxidized RyR1 channels leaked Ca(2+), resulting in lower intracel

89 )'s and Sm(3+)'s action was tested on single RyR1 channels reconstituted into planar lipid bilayers.

90 IC-A functions as an excitatory modulator of RyR1 channels within the SR terminal cisternae.

91 rmula: see text]) altered gating kinetics of RyR1 channels, increasing mean open time, decreasing mea

92 endent of Ca(2+) store depletion or block of RyR1 channels.

93 This protein, FKBP12, promotes the RyR1 closed state, thereby inhibiting Ca(2+) leakage in

94 that receive Ca(2+) signals through discrete RyR1 clusters, impacting gene expression through epigene

95 n of the skeletal muscle ryanodine receptor (RyR1) complex results in the rapid release of Ca(2+) fro

96 d then targeted these D-FKBPs to full-length RyR1 constructs containing decahistidine (His10) "tags"

97 ing involving cross-talk between IP(3)R1 and RyR1 contributes to Ca(2+) spark activation in skeletal

98 y, gene knockouts have revealed that CaV1.1/RyR1 coupling requires additional proteins, but leave op

99 mass spectrometry (yielding 93% coverage of RyR1 Cys residues) to identify 13 Cys residues subject t

100 that drugs that target ryanodine receptors (RyR1: dantrolene, tetracaine, S107) and L-type Ca(2+) ch

101 Here we show that the I4895T mutation in RyR1 decreases the amplitude of the sarcoplasmic reticul

102 ices were indistinguishable from those of WT RyR1, demonstrating our ability to modulate RyR1 gating

103 oteins affect the single-channel behavior of RyR1 derived from rabbit skeletal muscle.

104 BPA and TBBPA on ryanodine receptor type 1 (RyR1), dihydropyridine receptor (DHPR), and sarcoplasmic

105 A RyR1 disease mutation, N760D, appears to directly impact

106 1 ryanodine receptor/Ca(2+) release channel (RyR1) display muscle weakness and atrophy, but the under

107 that Ca(V)1.1 functions not only to activate RyR1 during EC coupling, but also to suppress resting Ry

108 CE and also intracellular Ca(2+) release via RyR1 during skeletal muscle contraction.

109 In this study, we investigated whether the RyR1-E4242G mutation affects retrograde coupling.

110 activation kinetics of the L-type current in RyR1-E4242G myotubes resembled those of normal myotubes,

111 L-type current in myotubes homozygous for RyR1-E4242G was substantially reduced in amplitude ( app

112 When CaM is bound to full-length RyR1, either purified or in SR membranes, strikingly dif

113 tal myopathy harbored recessive mutations in RYR1, encoding the ryanodine receptor 1, and were suscep

114 by equilibrium binding of [(3)H]ryanodine to RyR1-enriched microsomes, the mixture and the individual

115 ing the phenotype of the parent carrying the RYR1 ex36 mutation and suggests that in skeletal muscle

116 odel knocked-in for a frameshift mutation in RYR1 exon 36 (p.Gln1970fsX16) that is isogenic to that i

117 In addition, a retrograde signal from the RyR1 facilitates gating of the voltage-gated calcium cha

118 S107 (a stabilizer of RyR1-FK506 binding protein coupling that reduces Ca(2+)

119 skeletal muscle function by stabilizing the RyR1-FKBP12 complex.

120 wever, the same HIIT exercise does not cause RyR1 fragmentation in muscles of elite endurance athlete

121 usion, HIIT exercise induces a ROS-dependent RyR1 fragmentation in muscles of recreationally active s

122 performing the same HIIT exercise showed no RyR1 fragmentation or prolonged changes in the expressio

123 tive oxygen/nitrogen species (ROS)-dependent RyR1 fragmentation, calpain activation, increased SR Ca(

124 This individual carrying the RYR1 frameshifting mutation complained of mild muscle we

125 We find that RyR1 from Tric-a KO mice are more sensitive to inhibitio

126 Additionally, RyR1 from Tric-a KO mice are not activated by protein ki

127 of Mg(2+) , ATP cannot effectively activate RyR1 from Tric-a KO mice.

128 el required for skeletal muscle contraction; RyR1) from aged MCat mice was less oxidized, depleted of

129 Although the role of the EF-hand domain in RyR1 function has been studied extensively, little is kn

130 ) in the skeletal muscle ryanodine receptor (RyR1) functions as a Ca(2+) sensor that regulates the ga

131 rminant(s) for the physical link of DHPR and RyR1, further confirming a direct correspondence between

132 The role of RyR1-G4934 and -G4941 in the pore-lining helix in channe

133 and close times were observed between WT and RyR1-G4934A and -G4941A.

134 RyR1-G4934A had reduced K(+) conductance and ion selecti

135 RyR1-G4934A, -G4941A, and -G4941V mutant channels exhibi

136 Co-expression of RyR1-WT with RyR1-G4934V or -G4941I partially restored the WT phenoty

137 RyR1-G4941K did not fully close at nanomolar cytosolic C

138 Ca(2+)- and voltage-dependent regulation of RyR1-G4941K mutant channels was demonstrated.

139 We therefore investigated whether RyR1 gating behaviour is modified in the SR from Tric-a

140 The defective RyR1 gating that we describe probably contributes signif

141 RyR1, demonstrating our ability to modulate RyR1 gating without affecting ion permeation.

142 the hypothesis that this interface controls RyR1 gating, we designed mutations in the linker helix t

143 Mutations in the RYR1 gene cause severe myopathies.

144 Mutations in the ryanodine receptor 1 (RYR1) gene are associated with several human congenital

145 The absence of high-resolution structures of RyR1 has limited our understanding of channel function a

146 Heterozygous R163C-RYR1 (HET) MH susceptible mice are used to investigate t

147 ween recombinant cav-3 nonamers and purified RyR1 homotetramers that would imply that at least one of

148 e sarcoplasmic reticulum proteins Serca1 and Ryr1 in a pattern indicative of colocalization with the

149 Here we report the structure of the rabbit RyR1 in complex with its modulator FKBP12 at an overall

150 specific miRNAs, whereas acute knock-down of RYR1 in mouse muscle fibres by siRNA caused up-regulatio

151 uted widely within the cytoplasmic domain of RyR1 in multiple functional domains implicated in RyR1 a

152 Here, we present cryo-EM reconstructions of RyR1 in multiple functional states revealing the structu

153 ess interlobe distances when CaM is bound to RyR1 in SR membranes, purified RyR1, or a peptide corres

154 S107 increased FKBP12 binding to RyR1 in SR vesicles in the presence of reduced glutathio

155 ) Ca(2+) release channel/ryanodine receptor (RyR1) in the diaphragm.

156 asma membrane and type 1 ryanodine receptor (RyR1) in the sarcoplasmic reticulum (SR) is thought to u

157 Ca(2+) release channel ryanodine receptor 1 (RyR1) in the sarcoplasmic reticulum (SR).

158 ates opening of the calcium release channel (RyR1) in the sarcoplasmic reticulum that supplies the ca

159 Rs interact with type 1 ryanodine receptors (RyR1) in the sarcoplasmic reticulum.

160 from the SR and retrograde coupling by which RyR1 increases the magnitude of the Ca(2+) current via C

161 lts in an approximately 16 times more potent RyR1 inhibitor (IC(50) = 0.24 +/- 0.05 muM) compared wit

162 h the functional role of Stac3 in the CaV1.1-RyR1 interaction.

163 odulate the skeletal muscle channel isoform (RyR1) interaction with calmodulin and FK506 binding prot

164 , which are thought to mediate direct beta1a-RyR1 interactions, weakened EC coupling but did not repl

165 from Tric-a KO mice by incorporating native RyR1 into planar phospholipid bilayers under voltage-cla

166 The skeletal muscle calcium release channel RyR1 is activated by Ca(2+)-free CaM and inhibited by Ca

167 S-Oxidation of RyR1 is coupled to muscle oxygen tension (pO2) through O

168 dent structural distribution of CaM bound to RyR1 is distinct from that of CaM bound to RyRp.

169 The ryanodine receptor ion channel RyR1 is present in skeletal muscle and has a large cytop

170 We propose that the function of RyR1 is tuned to the Ca(2+)-dependent structural dynamic

171 nature of how Stac3 acts on the DHPR and/or RyR1 is unknown.

172 The type-1 ryanodine receptor (RyR1) is an intracellular calcium (Ca(2+)) release chann

173 The type 1 ryanodine receptor (RyR1) is expressed widely in the brain, with high levels

174 predominant form of RyR in skeletal muscle, RyR1, is subject to Cys-directed modification by S-palmi

175 calcium release channel (ryanodine receptor, RyR1 isoform) via a mechanism dependent on the conformat

176 terozygous (Het) and homozygous (Hom) T4826I-RYR1 knock-in mice.

177 r study focuses on the MH susceptible G2435R-RYR1 knock-in mouse model, which is the murine equivalen

178 vide evidence of metabolic defects in G2435R-RYR1 knock-in mouse muscle under basal conditions.

179 le promoting intracellular Ca(2+) release in Ryr1 knockout cells.

180 PT1 and MICU1), and 7 had variants in TTN or RYR1, large genes that are technically difficult to Sang

181 turbation of Ca(V)1.1 negative regulation of RyR1 leak identifies a unique mechanism that can sensiti

182 We found that inhibiting RyR1 leakage, TGF-beta signaling, TGF-beta release from

183 2+) release in skeletal muscle by binding to RyR1 low affinity sites.

184 522S mutation causes greater openness of the RyR1, lowers resting [Ca2+]SR and alters SR Ca2+ bufferi

185 The RyR1 macromolecular complex was oxidized, S-nitrosylated

186 We found that in the absence of RyR1, measureable FRET occurred between the N terminus a

187 We show that ryanodine receptor 1 (Ryr1)-mediated Ca(2+) leak is an important mechanism for

188 and that in its absence OSI causes increased RyR1-mediated Ca(2+) leak from the SR into the cytoplasm

189 ng EC coupling, but also to suppress resting RyR1-mediated Ca(2+) leak from the SR, and that perturba

190 K201 (>/=5 microM) increased RyR1-mediated Ca(2+) release from SkM microsomes.

191 The type 1 ryanodine receptor (RyR1) mediates Ca(2+) release from the sarcoplasmic reti

192 n human plasma exacerbates the penetrance of RYR1 MH susceptibility mutations triggered by gaseous an

193 Comparisons between WT and homozygous G2435R-RYR1 mitochondria showed a significant increase in compl

194 In this study, we identify a mouse RyR1 model in which heterozygous animals display clinica

195 To this end, we generated an open-channel RyR1 model using molecular simulations to pull Ca(2+) th

196 line that effectively filters small-molecule RyR1 modulators towards clinical relevance.

197 cles), an average of six to eight Cys thiols/RyR1 monomer are reversibly oxidized at high (21% O2) ve

198 ut their identity among the 100 Cys residues/RyR1 monomer is unknown.

199 reactive oxygen species production in G2435R-RYR1 muscle fibers.

200 Following purification, the RyR1 mutants G4934D, G4934K, and G4941D did not noticeab

201 ith mitochondria and fatty acid oxidation in RYR1 mutants when compared with WT controls.

202 Recent studies of RyR1 mutants, including the article by Bannister et al.

203 The RyR1 mutation decreases sensitivity to activated calcium

204 ossibly in humans carrying the corresponding RyR1 mutation.

205 ted in both heat-sensitive MHS patients with RYR1 mutations and YS mice due to Ca(2+) driven increase

206 Patients carrying RYR1 mutations are at high risk of developing malignant

207 t muscle biopsies of patients with recessive RYR1 mutations exhibit decreased expression of muscle-sp

208 mmon feature of diseases caused by recessive RYR1 mutations is a decrease of ryanodine receptor 1 pro

209 e model knocked-in for the Q1970fsX16+A4329D RYR1 mutations, which are isogenic with those identified

210 e muscle damage of myopathies due to certain RyR1 mutations.

211 f acute and chronic diseases associated with RYR1 mutations.

212 Recessive ryanodine receptor 1 (RYR1) mutations cause congenital myopathies including mu

213 plegia can result from ryanodine receptor 1 (RYR1) mutations without overt associated skeletal myopat

214 potential as a therapeutic intervention for RyR1 myopathies that are associated with ER stress.

215 iochemistry and pathophysiology of recessive RYR1 myopathies, here we investigated a mouse model we r

216 These findings further imply that the RyR1 N-terminal and central domains are proximal to one

217 d those of normal myotubes, unlike dyspedic (RyR1 null) myotubes in which the L-type currents have ma

218 bility (Po) of very active ("high-activity") RyR1 of SkM reconstituted into bilayers, but it had no e

219 at use of ion-pulling simulations produces a RyR1 open-channel model, which can provide insights into

220 ticulum (SR) caused by missense mutations in RYR1 or CACNA1S, and the MH crisis has been attributed s

221 s consisting of residues 850-1,056 in rabbit RyR1 or residues 861-1,067 in mouse RyR2.

222 M is bound to RyR1 in SR membranes, purified RyR1, or a peptide corresponding to the CaM-binding doma

223 In particular, the bi-allelic RyR1 p.A4329D mutation caused a milder phenotype than it

224 In summary, bi-allelic expression of the RyR1 p.A4329D mutation phenotypically differs from mono-

225 llelic versus mono-allelic expression of the RyR1 p.A4329D mutation.

226 Exogenous expression of wild-type RyR1 partially restored L-type current density.

227 ses to heat and exercise in individuals with RYR1 pathogenic variants.

228 everal crystal structures of skeletal muscle RyR1 peptide fragments have been solved, but these cover

229 onist isoproterenol (isoprenaline) increased RyR1 PKA phosphorylation, twitch Ca(2+) and force genera

230 m these studies we draw two conclusions: (i) RyR1 plays a role in VICaR in hypothalamic nerve termina

231 Here we demonstrate that RyR1 plays a role in VICaR in nerve terminals.

232 The RyR1 pore architecture places it in the six-transmembran

233 g six transmembrane helices to calculate the RyR1 pore region conductance, to analyze its structural

234 ave reported a hypothetical structure of the RyR1 pore-forming region, obtained by homology modeling

235 d by a glycine for glutamate substitution at RyR1 position 4242.

236 Analysis of the RyR1 protein content in a muscle biopsy from this indivi

237 RyR1 protein content in the muscles of mutant mice reach

238 The decrease of RyR1 protein content in total homogenates is not accompa

239 emical analysis reveals a marked decrease in RYR1 protein levels (20% of normal) as compared to only

240 blished, its binding determinants within the RyR1 protein sequence remain unresolved.

241 Here, we show in muscle cells from MH-RyR1(R163C) knock-in mice that increased passive SR Ca(2

242 sed, and [Na]i is chronically elevated in MH-RyR1(R163C) muscle cells.

243 ivo and further increased by halothane in MH-RyR1(R163C/WT) muscle.

244 + 2 mM ATP), dantrolene caused inhibition of RyR1 (rabbit skeletal muscle) and RyR2 (sheep) with a ma

245 Ryanodine receptor type I (RYR1)-related myopathies (RYR1 RM) are a clinically and

246 an important pathophysiological mechanism in RYR1-related myopathies and that N-acetylcysteine is a s

247 While ophthalmoplegia occurs rarely in RYR1-related myopathies, these children were atypical be

248 Ryanodine receptor type 1 (RyR1) releases Ca(2+) from intracellular stores upon ner

249 nd mutations in the ryanodine receptor gene (RYR1) represent the most frequent cause of these conditi

250 stablishing the pathomechanisms of recessive RYR1 RM and pre-clinical testing of therapies for effica

251 clinical presentation seen in a subgroup of RYR1 RM children.

252 xhibit a post-natal lethal recessive form of RYR1 RM that pheno-copies the severe congenital clinical

253 e receptor type I (RYR1)-related myopathies (RYR1 RM) are a clinically and histopathologically hetero

254 to generate a novel recessive mouse model of RYR1 RM.

255 crease in resting Ca(2+) in myotubes from an RYR1-RM mouse model.

256 This unique platform for RYR1-RM therapy development is potentially applicable to

257 yanodine receptor type I-related myopathies (RYR1-RMs) are a common group of childhood muscle disease

258 y is to identify new therapeutic targets for RYR1-RMs.

259 DM stabilized channel open states of RyR1, RyR2, and cortical preparations expressing all thr

260 The RyR1 S6 pore-lining helix has two conserved glycines, Gl

261 e energy transfer (FRET) measurements to map RyR1 sequence elements forming the binding site of the 1

262 these cover less than 15% of the full-length RyR1 sequence.

263 nonessential role in the bidirectional DHPR/RyR1 signaling that supports skeletal-type EC coupling.

264 drugs with the aim of functionally modifying RyR1 single-channel activity.

265 CAF +/- HAL are studied on RYR1 single-channel currents and HET myotubes to define

266 ex of the rabbit skeletal muscle type 1 RyR (RyR1), solved by single-particle electron cryomicroscopy

267 crease of Cav1.1 content, whereby the Cav1.1/RyR1 stoichiometry ratio in skeletal muscles from RyR1Q1

268 e pore constriction site of a closed-channel RyR1 structure determined at 3.8-A resolution.

269 sites is exposed within the fully assembled RyR1 structure.

270 conclude that mutating residue E4242 affects RyR1 structures critical for retrograde communication wi

271 989G and R3772W) and 2 compound heterozygous RYR1 substitutions (H283R and R3772W) were identified in

272 Furthermore, a direct interaction with RyR1 suggests a possible role for cav-3 as a modifier of

273 The calculated conductance of the wild-type RyR1 suggests that the proposed pore structure can susta

274 Ryanodine receptor subtype 1 (RyR1) supports relaxation of arterial myocytes by unload

275 ion T4825I in the type 1 ryanodine receptor (RYR1(T4825I/+)) confers human malignant hyperthermia sus

276 Heterozygous RYR1(T4826I/+) (Het) or homozygous RYR1(T4826I/T4826I) (

277 erozygous RYR1(T4826I/+) (Het) or homozygous RYR1(T4826I/T4826I) (Hom) mice are fully viable under ty

278 n RyR1 bound approximately 48 [(3)H]S107 per RyR1 tetramer with EC(50) approximately 52 microM and Hi

279 metastases also had oxidized skeletal muscle RyR1 that is not seen in normal muscle.

280 tion to the orthograde signal from CaV1.1 to RyR1 that triggers Ca(2+) release from the sarcoplasmic

281 mutations in the type 1 ryanodine receptor, RyR1, the Ca2+ channel of the sarcoplasmic reticulum (SR

282 pposed near the FKBP binding site within the RyR1 three-dimensional structure.

283 al to both N-terminal and central domains of RyR1, thus suggesting that the FKBP binding site is comp

284 plasmic reticulum, retrograde signaling from RyR1 to CaV1.1 results in increased amplitude and slowed

285 ightly controls gating of the pore domain of RyR1 to release Ca(2+).

286 st specific negative allosteric modulator of RyR1, to our knowledge, and represents a lead compound f

287 of MH in the United Kingdom is the c.7300G>A RYR1 variant, which is present in ~16% of MH families.

288 In contrast, wildtype RyR1 was closed and not activated by luminal Ca(2+) at l

289 Reduced RyR1 was greater than that of RyR3.

290 sing overlapping peptides tested on isolated RyR1, we hypothesized that a 19-amino-acid residue pepti

291 The effects of S107 and FKBP12 on RyR1 were examined under conditions that altered the red

292 These posttranslational modifications of RyR1 were mediated by both oxidative stress mediated by

293 reconstructions of open and closed states of RyR1 were obtained from the same sample, enabling analys

294 reased Nox4 binding to RyR1 and oxidation of RyR1 were present in a mouse model of Camurati-Engelmann

295 In conclusion, FKBP12.6 activates RyR1, whereas FKBP12 activates RyR2 and this selective a

296 within the N-terminal, cytoplasmic region of RyR1, which are clustered in multiple functional domains

297 (4892)AGGG-F(4921) residues in the cavity of RyR1, which explain the effects of the corresponding mut

298 ty-governing protein-protein interactions of RyR1 with the L-type Ca(2+) channel CaV1.1, calmodulin,

299 Co-expression of RyR1-WT with RyR1-G4934V or -G4941I partially restored t

300 Mice with an MHS-associated mutation in Ryr1 (Y524S, YS) display lethal muscle contractures in r

301 iants in several other candidates, including RYR1, ZFPM1, CAMTA2, DLX6, and PCM1.